Why Is There No Benefit To Cancer Specific Survival?

Why Is There No Benefit To Cancer Specific Survival?

Cancer-News

1 month
7 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Anurag Singh, MD of Roswell Park explains a commonly asked question by colleagues: why is there no benefit to cancer specific survival?

_______

Roswell Park researchers present findings at ASTRO Annual Meeting

  • Aspirin improved overall survival for patients with head/neck, lung cancers
  • Patients in both studies also received radiation or chemoradiation therapy
  • Future studies will help determine which patients benefit most 
     

BUFFALO, N.Y. — What if a drug that sits in nearly everyone’s medicine cabinet could help extend the lives of some cancer patients? In companion presentations at the American Society for Therapeutic Radiation Oncology (ASTRO) Annual Meeting in Chicago, doctors from Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing treatment for some head/neck and lung cancers.

The retrospective analyses are the first to suggest a benefit in overall survival for patients with either head and neck squamous cell carcinoma (HNSCC) or early-stage non-small cell lung cancer (NSCLC) who received non-steroidal anti-inflammatory drugs (NSAIDs) — most commonly, low-dose aspirin — alongside standard radiation therapy or chemoradiation therapy.

Read here: https://www.oncologytube.com/video/taking-baby-aspirin-improves-overall-survival-for-patients-with-head-neck-lung-cancer

Up Next Autoplay
Taking Baby Aspirin Improves  Overall Survival for Patients: What's Next For Research?
Taking Baby Aspirin Improves Overall Survival for Patients: What's Next For Research?
Category: Head and Neck Cancers
6 Views
Cancer-News 1 month
Taking Baby Aspirin Improves Overall Survival for Patients
Taking Baby Aspirin Improves Overall Survival for Patients
Category: Head and Neck Cancers
22 Views
Cancer-News 1 month
Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer
Taking Baby Aspirin Improves Overall Survival for Patients With Head & Neck, Lung Cancer
Category: Head and Neck Cancers
17 Views
Cancer-News 2 months
Cemiplimab in cSCC Updated Data
Cemiplimab in cSCC Updated Data
Category: Head and Neck Cancers
108 Views
obr 4 months
Importance of Stratification by PD-L1 Score
Importance of Stratification by PD-L1 Score
Category: Head and Neck Cancers
58 Views
obr 4 months
Thoughts on KEYNOTE-048
Thoughts on KEYNOTE-048
Category: Head and Neck Cancers
89 Views
obr 4 months
LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Category: Head and Neck Cancers
16 Views
Annual-Meeting 5 months
Primary analysis of Phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC).
Primary analysis of Phase 2 results of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with locally advanced cutaneous squamous cell carcinoma (laCSCC).
Category: Head and Neck Cancers
308 Views
Annual-Meeting 5 months
Who Should Get Monotherapy Or Pembrolizumab Combo: Reasonable To Use Pembrolizumab Monotherapy In Patients That Have CPS Greater Than 20
Who Should Get Monotherapy Or Pembrolizumab Combo: Reasonable To Use Pembrolizumab Monotherapy In Patients That Have CPS Greater Than 20
Category: Head and Neck Cancers
44 Views
Annual-Meeting 5 months